Galderma Reports Positive Results for Facial Volume Loss Tied to Medication-Driven Weight Loss
The phase IV trial evaluated outcomes of Sculptra plus Restylane Lyft or Contour in patients with facial volume loss due to weight loss medications.
The phase IV trial evaluated outcomes of Sculptra plus Restylane Lyft or Contour in patients with facial volume loss due to weight loss medications.
Guidepoint Qsight’s Erik Haines breaks down the drivers behind 2024’s $17.5 billion in non-surgical aesthetic spending and what it signals for the future of the industry.
Most patients continue to lose weight in the years after abdominoplasty, with an average 10-pound drop five years post-op.
A new ISAPS report shows a facial procedure has overtaken liposuction as the most-performed surgery worldwide.
While known for cosmetic procedures, Raghu Athré also provides reconstructive care to patients facing medical and financial hardship.